Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides

Posted on: Monday, 1 December 2008, 00:30 CST

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- On Monday, December 1, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the agreement with Spectrum Pharmaceuticals of Irvine, California to jointly market and develop Zevalin(R). The call will be webcast with slides, and the slides are also available for review on CTI's website, http://www.celltherapeutics.com/investor_updates.

Conference Call Numbers Monday, December 1 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-800-219-6110 (US Participants) 1-303-262-2053 (International) Call-back numbers for post-listening available at 11:30 a.m. Eastern: 1-800-405-2236 (US Participants) 1-303-590-3000 (International) Passcode: 11123066#

Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.

Slides for the webcast can be accessed at: http://www.celltherapeutics.com/investor_updates Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 F: 206.272.4434 E: media@ctiseattle.com www.celltherapeutics.com/press_room Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch Logan T: 206.272.4347 F: 206.272.4434 E: invest@ctiseattle.com www.celltherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.


Source: PR Newswire

More News in this Category

Related Articles

Rating: 3.3 / 5 (4 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required

Related Videos

Most Popular Stories

redOrbit Friends